Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

Ralf-Dieter Hofheinz,A. Willer,A. Weisser,U. Gnad,Susanne Saussele,Sebastian Kreil,J. T. Hartmann,R. Hehlmann,Andreas Hochhaus

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

2004

Ralf-Dieter Hofheinz
A. Willer
A. Weisser
U. Gnad
Susanne Saussele
Sebastian Kreil
J. T. Hartmann
R. Hehlmann
Andreas Hochhaus

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

Keywords:

Fluorouracil
Mitomycin C
Stomach cancer
Doxorubicin
Immunology
Cancer
Folinic acid
Medicine
Pharmacology
Antimetabolite
Gastrointestinal cancer
Toxicity
Mucositis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations